ERYTECH Pharma S.A (ERYP)

Etorro trading 970x250
ERYTECH Pharma S.A (ERYP) Logo

About ERYTECH Pharma S.A

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine-dependent cancers. It has research collaborations with the Fox Chase Cancer Center to advance the preclinical development of erymethionase for the treatment of homocystinuria; and Queen’s University of Canada to advance the preclinical development of eryminase for the treatment of arginase-1-deficiency. The company was incorporated in 2004 and is headquartered in Lyon, France. Address: 60 Avenue Rockefeller, Lyon, France, 69008

ERYTECH Pharma S.A News and around…

Latest news about ERYTECH Pharma S.A (ERYP) common stock and company :

56 Biggest Movers From Yesterday
26 Oct, 2021 FinancialContent

Gainers Bakkt Holdings, Inc. (NYSE: BKKT) shares jumped 234.4% to close at $30.60 on Monday after the company and Mastercard ...

Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Bakkt Holdings Shares Spike Higher
25 Oct, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.26% to 35,771.26 while the NASDAQ rose 1.01% to 15,241.89. The S&P also rose, ...

12 Health Care Stocks Moving In Monday's Intraday Session
25 Oct, 2021 FinancialContent

Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current ...

Mid-Day Market Update: Crude Oil Rises Over 1%; ERYTECH Pharma Shares Plummet
25 Oct, 2021 FinancialContent

Midway through trading Monday, the Dow traded up 0.14% to 35,726.52 while the NASDAQ rose 0.52% to 15,168.16. The S&P also rose, ...

35 Stocks Moving In Monday's Mid-Day Session
25 Oct, 2021 FinancialContent

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares jumped 122% to $1.8895 after the company announced its incubated company ...

Mid-Morning Market Update: Markets Edge Higher; Kimberly Clark Cuts FY21 Forecast
25 Oct, 2021 FinancialContent

Following the market opening Monday, the Dow traded up 0.07% to 35,700.45 while the NASDAQ rose 0.31% to 15,136.85. The S&P also ...

ERYTECH Pharma Stock Tumbles after Pancreatic Cancer Trial Disappoints
25 Oct, 2021 Yahoo! Finance

By Sam Boughedda

12 Health Care Stocks Moving In Monday's Pre-Market Session
25 Oct, 2021 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
25 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We're kicking off another busy week of trading with lists of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

24 Stocks Moving in Monday's Pre-Market Session
25 Oct, 2021 FinancialContent

Gainers Remark Holdings, Inc. (NASDAQ: MARK) rose 260% to $7.80 in pre-market trading after jumping 138% on Friday. Sonim ...

ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer
25 Oct, 2021 Yahoo! Finance

ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Second-line Advanced Pancreatic Cancer Management to host Conference Call on Monday, October 25,at 8:30am EDT/ 2:30pm CEST The trial did not meet its primary endpoint of overall survivalThe prespecified subgroup of patients treated with eryaspase and an irinotecan-based chemotherapy demonstrated an interesting trend of survival benefit, which merits further investigationPatients treated with eryaspase demonstrat

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Oct, 2021 FinancialContent

Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's ...

12 Health Care Stocks Moving In Thursday's After-Market Session
07 Oct, 2021 FinancialContent

Gainers Vaxart (NASDAQ:VXRT) shares increased by 12.27% to $7.96 during Thursday's after-market session. This security traded at a ...

Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2021.
07 Oct, 2021 Yahoo! Finance

Monthly information related to total number of voting rights and shares composing the share capital – September 30, 2021. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of ne

ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
04 Oct, 2021 Yahoo! Finance

ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer No dose-limiting toxicity (DLT) reported in first two dose cohorts, leading to declaration of the maximum tolerated dose (MTD) at 100 U/kgEncouraging clinical activity observed in first patients Lyon (France) and Cambridge, MA (U.S.), October 4, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative the

ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech
28 Sep, 2021 Yahoo! Finance

ERYTECH to Participate in the HealthTech Innovation Days (HTID) by France Biotech Cambridge, MA (U.S.) and Lyon (France), September 28, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the company’s participation in one-on-one investor meetings at the HealthTech Innovation Days (HTID) by France Biotech being held in Paris and virtually on

ERYTECH Announces the Availability of its Half-Year Financial Report 2021
22 Sep, 2021 Yahoo! Finance

ERYTECH Announces the Availabilityof its Half-Year Financial Report 2021 Lyon (France) and Cambridge, MA (U.S.), Septembre 22, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that it had filed with the Autorité des Marchés Financiers (AMF) its half-year report for the six-month period ended June 30, 2021. The half-year financial report is avai

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021
20 Sep, 2021 Yahoo! Finance

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2021 Conference call and webcast on Tuesday, September 21, 2021at 8:30am EDT / 2:30pm CET TRYbeCA-1 Phase 3 trial of eryaspase in second-line metastatic pancreatic cancer fully enrolled since January 2021; on track for final results in Q4 2021 Fast Track designation received for eryaspase in treatment of ALL patients who developed hypersensitivity reactions to pegylated asparaginase; working towards potential BL

Stock Market News For Today September 20, 2021
20 Sep, 2021 FinancialContent
Earnings Scheduled For September 20, 2021
20 Sep, 2021 FinancialContent

Companies Reporting Before The Bell • Cognyte Software (NASDAQ:CGNT) is expected to report quarterly earnings at $0.15 ...

ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update
15 Sep, 2021 Yahoo! Finance

ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and Business Update Lyon (France) and Cambridge, MA (U.S.), September 15, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its second quarter 2021 conference call and webcast on Tuesday, September 21, 2021, at 2:30 PM CEST/8:30 AM ET to discuss ope

ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
06 Sep, 2021 Yahoo! Finance

ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Cambridge, MA (U.S.) and Lyon (France), September 6, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that its CEO, Gil Beyen, will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The Conference will be held virtually with all parti

Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2021
03 Sep, 2021 Yahoo! Finance

Monthly information related to total number of voting rights and shares composing the share capital – August 31, 2021. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (

ERYTECH to Participate in the Citi 16th Annual BioPharma Conference
30 Aug, 2021 Yahoo! Finance

ERYTECH to Participate in the Citi 16th Annual BioPharma Conference Cambridge, MA (U.S.) and Lyon (France), August 30, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced its participation in the Citi 16th Annual BioPharma Conference and invites investors to join virtually via one-on-one meetings. Citi’s 16th Annual BioPharma Conference– Sep

ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
24 Aug, 2021 Yahoo! Finance

ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer Webinar on Wednesday, September 1st @ 10am ET/4pm CET Cambridge, MA (U.S.) and Lyon (France), August 24, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company, leader in red blood-cell based cancer therapeutics, announced today it will host a key opinion leader webinar on its lead product candidate eryaspase, L-asparaginase encapsulated in donor-derived red blood cells, on Wednesday

Papyrus Therapeutics Inc. Announces Additions to Its Board of Directors
17 Aug, 2021 FinancialContent

Papyrus Therapeutics Inc. announces additions to its Board of Directors.

12 Health Care Stocks Moving In Friday's After-Market Session
06 Aug, 2021 FinancialContent

Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value of their ...

Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021
05 Aug, 2021 Yahoo! Finance

Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2)

12 Health Care Stocks Moving In Monday's After-Market Session
02 Aug, 2021 FinancialContent

Gainers F-star Therapeutics (NASDAQ:FSTX) stock rose 9.3% to $5.99 during Monday's after-market session. The company's market cap ...

40 Stocks Moving In Monday's Mid-Day Session
02 Aug, 2021 FinancialContent

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million ...

ERYTECH Pharma S.A (ERYP) is a NASDAQ Common Stock listed in , ,

970x250